Healthline, New Delhi, September 2024: Recent research indicates that glucagon-like peptide-1 (GLP-1) receptor agonist drugs, such as Ozempic and Mounjaro, could prevent up to 34,000 heart attacks and strokes annually in the U.S. These medications, traditionally used for diabetes and obesity, have demonstrated cardiovascular benefits in previous trials for individuals […]
Healthline, New Delhi, September 2024: A study published in Neurology reveals that the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, which combines the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet, can slow cognitive decline, particularly in women. This new research has shown that adherence to the […]
Science News, August, 2024: COVID-19 diarrhea is a common symptom in people who contract the virus, with up to half experiencing it. About 30% of those who develop long COVID will also experience debilitating symptoms such as chronic pain, brain fog, shortness of breath, chest pain, and intense fatigue. The […]
Science News, August, 2024: The body’s biggest organ and an essential part of the immune system, the skin is shielded from the damaging effects of ultraviolet (UV) radiation by melanin. Tyrosinase is an essential component of the biosynthetic pathway, which is how melanocytes produce melanin in response to UV radiation […]
Science News, August, 2024: Scientists have identified and produced a class of chemicals that can function in an innovative manner against tuberculosis causation. They explain that, in contrast to antibiotics already in use, the so-called callyaerins combat infectious diseases through a radically different method. The callyaerins target Rv2113, a particular […]
The Indian Express, New Delhi, August 2024: The World Health Organization (WHO) has declared the latest mpox outbreak a Public Health Emergency of International Concern (PHEIC) following a surge in cases in the Democratic Republic of Congo (DRC) and neighboring countries. Since 2022, mpox—a viral infection caused by the mpox […]
The Hindu, New Delhi, August 2024: India has launched its first-ever phase 3 clinical trial for a dengue vaccine, involving over 10,335 healthy adult participants across 19 sites in 18 States and Union Territories. Panacea Biotec, with support from the Indian Council of Medical Research (ICMR), developed the indigenous tetravalent […]
Medscape, August, 2023: John M. Mandrola, MD, has raised the question whether the doctors should really follow the cardiology based published evidence in medical journals evolving from observational studies. Robert Yeh, MD, from Beth Israel in Boston has emphasized in his publication ‘Bringing the Credibility Revolution to Observational Research in […]
Shots, Health News from NPR, August 21, 2023: Ozempic and Wegovy, the diabetes and weight loss drugs created a buzz in the summers of 2022. Two clinical trials result on similar medication by pharmaceutical giant Eli Lilly astonished the doctors. Tirzepatide, traded as Mounjaro, specific for diabetes, eventually showed higher […]
The New York Times, August 21, 2023: After 50 years of repeated failed attempts of discovering respiratory syncytial virus (RSV) vaccine, The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention has approved Pfizer respiratory syncytial virus (RSV) vaccine – ABRYSVO™ for older adults, making […]